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LETTER TO THE EDITOR
COPD: From the stethoscope to
the  spirometer
a  well-known  phenomena,  as  was  the  conditions  of  work  in
cotton  factories.  In  1868,  Manchester’s  ﬁrst  Medical  Ofﬁcer
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tLetter  to  the  editor:
In  the  world,  about  3  billion  of  people,  predominantly
women,  young  girls  and  small  children,  are  exposed  to
household  air  pollution,  secondary  to  indoor  cooking  with
biomass  and  coal.1 Because  the  combustion  of  solid  fuels
produces  a  mixture  of  air  pollutants,  from  respirable  par-
ticles  to  gases,  this  exposure  is  associated  with  chronic
obstructive  pulmonary  disease  (COPD),  and  this  association
is  well  documented.2 During  their  lifetime,  some  women  can
be  exposed  to  biomass  smoke  for  30--40  years,  or  60,000  h
of  exposure.3 This  can  be  the  biggest  risk  factor  for  COPD
in  the  world,  even  predominates  in  developing  countries.4
In  rural  areas,  90%  of  households  continue  to  use  this  highly
polluting  biomass  fuel.  In  2008,  in  the  Portuguese  region  of
Lisbon,  the  BOLD  study  showed  a  GOLD  stage  1  or  higher
COPD  prevalence  of  9.2%  in  never-smokers.5
Despite  the  fact  that,  within  never-smokers,  COPD  has
been  neglected  and  excluded  in  the  majority  of  large
studies,6 the  association  observed  between  the  exposure  to
biomass  smoke  and  COPD  is  as  great  as  the  risk  of  active
smoking.  The  prevalence  of  COPD  among  never-smokers
varies  widely  across  the  countries,  but  at  least  one  fourth
of  patients  with  COPD  are  never-smokers.  Many  are  women,
in  whom  this  disease  is  understudied.7 But  cooking  with
biomass  and  coal,  rather  than  a  recent  phenomenon,  is  an
old  problem,  still  persisting  in  rural  areas  of  many  devel-
oped  countries,  as  in  Portugal,  Spain,  Canada,  Australia  or
US.  Thereby,  we  wonder  why  COPD  is  a  disease  only  recently
concern,  and  usually  associated  with  tobacco  epidemic.
In  fact,  the  recognition  of  emphysema  and  chronic
bronchitis,  and  the  evolution  of  their  knowledge,  cover
nearly  four  centuries,  since  the  Bonets’s  description  of
‘‘voluminous  lungs’’,  in  1679.8 In  1821,  Laënnec,  the  inven-
tor  of  the  stethoscope,  describes  the  emphysema  as  a
disease  that  was  ‘‘very  little  known’’  and  ‘‘completely  over-
looked’’.8 However,  since  the  discovery  and  use  of  the
stethoscope,  he  wrote,  he  believed  to  be  a  much  morePlease  cite  this  article  in  press  as:  Araújo  A.  COPD:  From  the
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common  problem.  With  Laënnec  begins  the  modern  era  of
COPD.  In  that  time  smoking  was  rare,  but  urban  atmospheric
pollution,  in  particular  coal  smoke,  and  domestic  pollution
from  open  ﬁreplaces,  in  houses  with  poor  ventilation,  was
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f  middle  age  in  Manchester  was  bronchitic.9 Occupation,
omestic  pollution  and  atmospheric  pollution  were,  in  the
9th  century,  well  known  risk  factors  for  chronic  bronchitis
nd  emphysema.
Until  recently,  the  diagnosis  of  emphysema  and  chronic
ronchitis  was  based  on  symptoms  of  dyspnea,  cough  and
xpectoration,  and  on  physical  examination  of  an  enlarged
hest.  The  diagnosis  of  emphysema,  according  to  Ronald
hristie,  in  1944,  should  be  considered  certain  in  the  pres-
nce  of  dyspnea  on  exertion  and  of  insidious  onset,  not  due
o  bronchospasm  or  left  ventricular  failure,  in  a  patient
ith  physical  signs  of  emphysema.  But  by  the  time  clini-
al  signs  are  present,  COPD  is  in  a  moderate  or  advanced
tage,10 and  we  miss  not  only  the  early  diagnosis  but  most
iagnosis.  Furthermore,  before  the  CIBA  Guest  Symposium,
n  1959,  and  the  American  Thoracic  Society  Symposium,
n  1962,  there  was  much  confusion  regarding  the  diagno-
is  of  chronic  bronchitis  and  emphysema,  and  the  concept
f  airﬂow  obstruction  was  only  introduced  at  that  time.11
radually,  doctors  and  scientists  concern  with  the  pathology
nd  the  clinic  moved  toward  the  pathophysiology,  giving  rise
o  the  actual  concept  of  COPD.
Cigarette  mass  production  began  circa  1880,  and  their
onsumption  has  increased  until  now,  but  the  association
ith  COPD  was  only  established  once  the  latent  effects  of
igarettes  became  apparent,  in  the  second  half  of  the  20th
entury.  With  the  progressive  increase  of  smoking,  initially
olely  in  the  developed  countries,  an  easier  access  to  the
uantiﬁcation  of  exposure,  and  a  well-documented  associa-
ion  to  COPD,  tobacco  smoking  became  the  most  important
isk  factor  for  COPD.  But  COPD,  even  under  the  old  label  of
mphysema  or  chronic  bronchitis,  was  probably  very  com-
on  before  tobacco  smoking  was  widespread,  although  little
ecognized.
In  1846  Hutchinson  invented  the  spirometer,  so  impor-
ant  to  the  diagnosis  of  COPD,  but  only  recently  the  industry
nd  technology  made  possible  the  emergence  of  handheld
pirometers,  accurate  and  inexpensive,  and  their  spread  in
he  primary  care  medicine,  although  there  is  a  lack  of  acces- stethoscope  to  the  spirometer.  Rev  Port  Pneumol.  2016.
ibility  in  our  country,  as  suggested  by  the  BOLD  study  in
isbon.5 FEV1/FVC,  more  than  deﬁning  obstruction,  is  a  sen-
itive  test  for  early  stages  of  airﬂow  limitation,  and,  when
70%,  heralds  the  onset  of  rapid  decline  in  FEV1.  The  Global
Elsevier España, S.L.U. This is an open access article under the CC
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nitiative  for  Chronic  Obstructive  Lung  Disease  (GOLD)  pro-
ram  was  initiated  in  1998,  and  the  ﬁrst  report  issued  in
001.12 Rather  than  a  new  disease,  the  generalization  of
hese  two  tools,  the  spirometer  and  the  GOLD  consensus
eport,  enabled  showing  COPD  as  a  common  disease  and  a
eading  cause  of  morbidity  and  mortality  worldwide,  giving
o  COPD  importance  and  visibility.
However,  the  term  COPD  is  more  than  a  new  label  for
n  old  disease:  is  a  new  concept,  as  proposed  by  the  GOLD
orking  deﬁnition;  is  chronic  and  common;  is  preventable
nd  treatable;  is  a  complex  disease  based  on  inﬂamma-
ion,  his  pathological  hallmark;  is  a  heterogeneous  disorder,
nd  also  heterogeneous  in  its  presentation.  And  exacerba-
ions  and  comorbidities  contribute  to  the  overall  severity.
ny  individual  patient  may  have  emphysema,  or  periph-
ral  airways  disease,  or  chronic  bronchitis,  or  all  of  these
onditions,13 but  the  dominant  clinical  feature  is  persistent
nd  usually  progressive  airﬂow  limitation,  that  is  the  hall-
ark  of  COPD.
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